Avalo Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
AVTX
CUSIP
05338F306
Type
Equity
Class
COM NEW
Num filings
37
Total reported value, excl. options
$39.1 M
Manager Report Date Value ($000) Shares Option Type